HIV/AIDS
New HIV/AIDS study findings recently were reported by researchers at Georgia State University
Published in Hematology Week, January 19th, 2009
"No drug has been targeted specifically for HIV-2 (human immunodeficiency virus type 2) infection despite its increasing prevalence worldwide. The antiviral HIV-1 (human immunodeficiency virus type 1) protease (PR) inhibitor darunavir and the chemically related GRL98065 and GRL06579A were designed with the same chemical scaffold and different substituents at P2 and P2' to optimize polar interactions for HIV-1 PR (PR1)," scientists writing in the Journal of Molecular Biology report.
"These inhibitors are also effective antiviral agents for HIV2-infected cells. Therefore, crystal structures of HIV-2 PR (PR2) complexes with the three inhibitors have been solved at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2009-01-19)
More Articles from Hematology Week
- BioMed Central
Metabolic syndrome risk for veterans with PTSD - Johns Hopkins Medical Institutions
Viagra's other talents: Help a 'signaling' protein shield the heart from high blood pressure damage - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Simple model predicts those at risk for chronic kidney disease - World Journal of Gastroenterology
The prevalence of gluten-sensitive enteropathy in iron-deficient anemia patients - Advanced Cell Technology, Inc.
Functional Vasculature Generated From Advanced Cell Technology’s Human Embryonic Stem Cells - Apoptosis
Reports summarize apoptosis research from University of Quebec - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
